Videos,
Mary Roberts Shares 2025 Market Access Insights
ADVI Health’s Mary Roberts, MPH, Senior Vice President, Market Access Strategy, sat down to share insights on the significant market access challenges that our team saw in 2024, and what we will be looking out for in 2025. Mary highlights key trends that we plan to monitor for our clients in the new year, notably relating to a possible increase in payer management in oncology and rare diseases, physician reimbursement, and more.
Hear more of Mary’s insights:
ADVI Health’s Mary Roberts, MPH, sat down to share insights on the significant market access challenges that we saw in 2024, and what we will be looking out for in 2025.
Panelists
Senior Vice President, Market Access Strategy
Mary leads ADVI’s Market Access strategy and solution team with over 25 years of expertise in developing comprehensive access and reimbursement strategies and tactics across multiple therapeutic areas and settings of care. She has extensive experience developing actionable strategic plans, and leading successful initiatives across the pharmaceutical industry, driving patient and provider confidence at launch and throughout the lifecycle of a product.
Full Transcript
Mary Roberts, MPH: One of the most significant challenges we saw in 2024 was assisting our clients in navigating the uncertainty in the market with the first round of IRA negotiations, election jitters, changes in the market, consolidation across the board. We were helping our clients navigate that uncertainty and predict what it would mean in the future.
As we think about key trends for 2025, we see many things coming to fruition, including increase payer management in areas that we haven’t seen historically in oncology and rare diseases, which only raises the importance of having a compelling value story for your brand, both from a clinical evidence standpoint and an economic impact standpoint. We saw many changes within the oncology landscape, particularly around physician reimbursement. You saw consolidation and realignment of stakeholders within that landscape, which changes the decision making and the valued proposition that brands need to have in order to make a compelling story within that market.
The other thing we saw in terms of key trends was the emergence of precision medicine. This is an area where ADVI shines. We are looking forward to helping clients both on the precision medicine and diagnostics side of the world – as well as our biopharma partners – better understand how they can unlock the potential of precision medicine to increase the number of products that come to market, get them to the market faster, and make sure that we are getting the right patient the right treatment at the right time.
In 2025, we look forward to helping our clients navigate this ever-changing landscape and the impact that it will have on their brands, portfolio, and pipeline. We look forward to working with you to navigate these challenging waters.
Learn More
Stay ahead of the curve this year. Get in touch today to gain expert insights and strategic counsel on the evolving healthcare landscape.